IP Library Granted Patent US 12,350,664
Granted Patent B2
US 12,350,664 · App. 17/331,554 · Granted Jul 8, 2025

Cartridges for cell processing

Inventors: Brian Alexander Pesch (San Francisco, CA); Fabian Gerlinghaus (South San Francisco, CA); Nicholas Scott Reimnitz (South San Francisco, CA)
Assignee: Cellares Corporation
B01L3/502715A61L2/04A61L2/20A61L2/206A61L2/208B01J19/004B01L13/00C12M23/44C12M23/50C12M41/48C12N5/00C12N5/0081A61L2/08A61L2202/11A61L2202/122A61L2202/123A61L2202/14B01J2219/0002B01J2219/0074B01L2200/027B01L2300/049
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,350,664
App. No.
17/331,554
Granted
Jul 8, 2025
Kind
B2
Abstract

Disclosed herein are cell processing systems, devices, and methods thereof. A system for cell processing may comprise a plurality of instruments each independently configured to perform one or more cell processing operations upon a cartridge, and a robot capable of moving the cartridge between each of the plurality of instruments.

Claims (33)

1. A cartridge for use in cell processing, comprising:

a plurality of cell processing modules defining an enclosed housing, wherein at least one module of the plurality of cell processing modules is selected from the group consisting of a cell selection module, an electroporation module, and a counterflow centrifugal elutriation (CCE) module, and at least one module of the plurality of cell processing modules comprises a bioreactor module;

a liquid transfer bus comprising a manifold, at least one fluid conduit, and at least one valve; and

a pump system comprising an opening in the enclosed housing and tubing in fluidic communication with the liquid transfer bus, wherein at least a portion of the tubing is externally exposed from the opening of the housing so as to be engageable by a pump actuator of an instrument within a cell processing workcell to move fluid within the cartridge,

wherein each cell processing module is fluidically coupled to the manifold of the liquid transfer bus, and

wherein the cartridge is sized and shaped to pass through a feedthrough of the cell processing workcell.

2. The cartridge of claim 1 , wherein the cartridge comprises one or more sterile liquid transfer ports.

3. The cartridge of claim 1 , wherein the plurality of cell processing modules of the cartridge comprises the cell selection module.

4. The cartridge of claim 3 , wherein the cell selection module is a magnetic-activated cell selection module.

5. The cartridge of claim 1 , wherein the plurality of cell processing modules of the cartridge further comprises a cell sorting module.

6. The cartridge of claim 5 , wherein the cell sorting module is a fluorescence activated cell sorting module.

7. The cartridge of claim 1 , wherein the plurality of cell processing modules of the cartridge comprises the electroporation module.

8. The cartridge of claim 1 , wherein the plurality of cell processing modules of the cartridge comprises the CCE module.

9. The cartridge of claim 1 , wherein the cartridge comprises a second bioreactor module.

10. The cartridge of claim 1 , wherein the plurality of cell processing modules of the cartridge comprises the bioreactor module, the cell selection module, and one or more of the CCE module and the electroporation module.

11. The cartridge of claim 1 , wherein one or more of the plurality of cell processing modules are moveable within the cartridge.

12. The cartridge of claim 1 , wherein actuation of the actuator of the instrument causes the at least one valve to move between a first position and a second position.

13. The cartridge of claim 8 , wherein the CCE module is configured to separate cells based on one or more of cell size and density.

14. The cartridge of claim 8 , wherein the CCE module comprises a subhousing comprising a rotor configured to separate cells from a fluid.

15. The cartridge of claim 14 , wherein the subhousing comprises one or more apertures configured to facilitate visualization of the rotor.

16. The cartridge of claim 14 , wherein one or more portions of the rotor is optically transparent.

17. The cartridge of claim 14 , wherein the rotor comprises a first side comprising a first fluid port and a second side comprising a second fluid port, the second side opposite the first side.

18. The cartridge of claim 17 , wherein at least a portion of the first fluid port and the second fluid port extend coaxially in parallel with each other.

19. The cartridge of claim 14 , wherein the rotor is configured to magnetically-engage a magnet of a corresponding instrument of the workcell.

20. The cartridge of claim 14 , wherein the rotor comprises an asymmetric shape.

21. The cartridge of claim 4 , wherein the magnetic-activated cell selection module comprises a flow cell.

22. The cartridge of claim 21 , wherein the flow cell comprises at least one elongate cavity.

23. The cartridge of claim 22 , wherein the at least one elongate cavity of the flow cell comprises a set of linear channels.

24. The cartridge of claim 21 , wherein the flow cell comprises a plurality of inlets and a plurality of outlets.

25. The cartridge of claim 1 , wherein the cartridge is movable relative to the instrument within the workcell by a robot.

26. The cartridge of claim 22 , wherein the elongate cavity is substantially empty prior to flow of biological material therethrough.

27. The cartridge of claim 1 , wherein the manifold is disposed within an exterior wall of the housing of the cartridge.

28. The cartridge of claim 1 , wherein the tubing is arranged around a circumference of the opening of the housing.

Assignments (2)
SECURITY INTEREST Recorded May 5, 2026
From: CELLARES CORPORATION
To: TRINITY CAPITAL INC.
Reel/Frame 075545/0558 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 6, 2021
From: GERLINGHAUS, FABIAN; PESCH, BRIAN ALEXANDER; REIMNITZ, NICHOLAS SCOTT; TOY, WILSON WAI; MALLEO, DANIELE; CHANG, CHIHWEI; THAKKAR, BHARAT S.; BIZ, TONY
To: CELLARES CORPORATION
Reel/Frame 057721/0587 →
Continuity (4)
Continuation 17198134 · Mar 10, 2021
Provisional Application 63093038 · Oct 16, 2020
Provisional Application 62987745 · Mar 10, 2020
Related Publication 20210354104A1 · Nov 18, 2021
References Cited (287)
US 3728227A · Elson et al. · 1973 [cited by applicant]
US 4234023A · Sogi et al. · 1980 [cited by applicant]
US 4696902A · Bisconte · 1987 [cited by applicant]
US 4751184A · Higo et al. · 1988 [cited by applicant]
US 4839292A · Cremonese · 1989 [cited by applicant]
US 4911833A · Schoendorfer et al. · 1990 [cited by applicant]
US 5058619A · Zheng · 1991 [cited by applicant]
US 5656491A · Cassani et al. · 1997 [cited by applicant]
US 6649419B1 · Anderson · 2003 [cited by applicant]
US 6891182B2 · Watari et al. · 2005 [cited by applicant]
US 7550287B2 · Dibino et al. · 2009 [cited by applicant]
US 7745209B2 · Martin et al. · 2010 [cited by applicant]
US 7816128B2 · Nakashima et al. · 2010 [cited by applicant]
US 8158426B2 · Wilson et al. · 2012 [cited by applicant]
US 8158427B2 · Wilson et al. · 2012 [cited by applicant]
US 8168432B2 · Wilson et al. · 2012 [cited by applicant]
US 8273572B2 · Martin et al. · 2012 [cited by applicant]
US 8415144B2 · Wilson et al. · 2013 [cited by applicant]
US 8440458B2 · Zijlstra et al. · 2013 [cited by applicant]
US 8470589B2 · Martin et al. · 2013 [cited by applicant]
US 8492140B2 · Smith et al. · 2013 [cited by applicant]
US 8546142B2 · Martin et al. · 2013 [cited by applicant]
US 8697443B2 · Wilson et al. · 2014 [cited by applicant]
US 8727132B2 · Miltenyi et al. · 2014 [cited by applicant]
US 8809044B2 · Wilson · 2014 [cited by applicant]
US 8846399B2 · Martin et al. · 2014 [cited by applicant]
US 8956860B2 · Vera et al. · 2015 [cited by applicant]
US 9040290B2 · Martin et al. · 2015 [cited by applicant]
US 9045721B2 · Martin et al. · 2015 [cited by applicant]
US 9080149B2 · Bosio et al. · 2015 [cited by applicant]
US 9255243B2 · Wilson et al. · 2016 [cited by applicant]
US 9279099B2 · Okano et al. · 2016 [cited by applicant]
US 9290730B2 · Martin et al. · 2016 [cited by applicant]
US 9410114B2 · Wilson et al. · 2016 [cited by applicant]
US 9441192B2 · Wilson et al. · 2016 [cited by applicant]
US 9499780B2 · Smith et al. · 2016 [cited by applicant]
US 9534195B2 · Smith et al. · 2017 [cited by applicant]
US 9556485B2 · Lin et al. · 2017 [cited by applicant]
US 9567565B2 · Vera et al. · 2017 [cited by applicant]
US 9597355B2 · Magnant · 2017 [cited by applicant]
US 9625463B2 · Miltenyi et al. · 2017 [cited by applicant]
US 9701932B2 · Smith et al. · 2017 [cited by applicant]
US 9732317B2 · Wilson · 2017 [cited by applicant]
US 9783768B2 · Larcher et al. · 2017 [cited by applicant]
US 9845451B2 · Martin et al. · 2017 [cited by applicant]
US 10047342B2 · Eibl et al. · 2018 [cited by applicant]
US 10053663B2 · Kabaha et al. · 2018 [cited by applicant]
US 10119970B2 · Miltenyi et al. · 2018 [cited by applicant]
US 10131876B2 · Kaiser et al. · 2018 [cited by applicant]
US 10253316B2 · Masquelier et al. · 2019 [cited by applicant]
US 10294658B2 · Scannon et al. · 2019 [cited by applicant]
US 10323258B2 · Bernate et al. · 2019 [cited by applicant]
US 10329559B1 · Masquelier et al. · 2019 [cited by applicant]
US 10385307B2 · Rowley et al. · 2019 [cited by applicant]
US 10421959B1 · Masquelier et al. · 2019 [cited by applicant]
US 10508288B1 · Bernate et al. · 2019 [cited by applicant]
US 10519437B1 · Masquelier et al. · 2019 [cited by applicant]
US 10533156B2 · Vera et al. · 2020 [cited by applicant]
US 10584333B1 · Masquelier et al. · 2020 [cited by applicant]
US 10584334B1 · Masquelier et al. · 2020 [cited by applicant]
US 10588994B2 · Kawamura et al. · 2020 [cited by applicant]
US 10620212B2 · Miltenyi et al. · 2020 [cited by applicant]
US 10689669B1 · Feldman et al. · 2020 [cited by applicant]
US 10705090B2 · Miltenyi et al. · 2020 [cited by applicant]
US 10705091B2 · Miltenyi et al. · 2020 [cited by applicant]
US 10723986B2 · Smith et al. · 2020 [cited by applicant]
US 10724043B2 · Sixto et al. · 2020 [cited by applicant]
US 10844338B1 · Smith et al. · 2020 [cited by applicant]
US 11161111B2 · Kabaha et al. · 2021 [cited by applicant]
US 11198845B2 · Parietti et al. · 2021 [cited by applicant]
US 11371018B2 · Shi et al. · 2022 [cited by applicant]
US 11376587B2 · Thakkar et al. · 2022 [cited by applicant]
US 11447745B2 · Shi et al. · 2022 [cited by applicant]
US 11701654B2 · Azersky et al. · 2023 [cited by applicant]
US 11786896B2 · Thakkar et al. · 2023 [cited by applicant]
US 11826756B2 · Azersky et al. · 2023 [cited by applicant]
US 11872557B2 · Biz et al. · 2024 [cited by applicant]
US 12157119B2 · Gerlinghaus et al. · 2024 [cited by applicant]
US 20030030272A1 · Johnson et al. · 2003 [cited by applicant]
US 20050070018A1 · Johnson et al. · 2005 [cited by applicant]
US 20050186671A1 · Cannon et al. · 2005 [cited by applicant]
US 20050260743A1 · Drake et al. · 2005 [cited by applicant]
US 20060194193A1 · Tsuruta et al. · 2006 [cited by applicant]
US 20060257999A1 · Chang et al. · 2006 [cited by applicant]
US 20070185472A1 · Baumfalk et al. · 2007 [cited by applicant]
US 20080057568A1 · Kan et al. · 2008 [cited by applicant]
US 20080176318A1 · Wilson et al. · 2008 [cited by applicant]
US 20090042281A1 · Chang et al. · 2009 [cited by applicant]
US 20090053799A1 · Chang-Yen et al. · 2009 [cited by applicant]
US 20090247417A1 · Haas et al. · 2009 [cited by applicant]
US 20100130732A1 · Chung et al. · 2010 [cited by applicant]
US 20100151571A1 · Vukasinovic et al. · 2010 [cited by applicant]
US 20110003380A1 · Miltenyi · 2011 [cited by examiner]
US 20110223064A1 · Katsumi et al. · 2011 [cited by applicant]
US 20110229927A1 · Larsen et al. · 2011 [cited by applicant]
US 20110262896A1 · Blecka et al. · 2011 [cited by applicant]
US 20120138156A1 · Hofman et al. · 2012 [cited by applicant]
US 20120283867A1 · Gelbman et al. · 2012 [cited by applicant]
US 20120293338A1 · Chaffey et al. · 2012 [cited by applicant]
US 20130078624A1 · Holmes et al. · 2013 [cited by applicant]
US 20130115617A1 · Wilson et al. · 2013 [cited by applicant]
US 20130132006A1 · Gwynn et al. · 2013 [cited by applicant]
US 20140309795A1 · Norton et al. · 2014 [cited by applicant]
US 20150307829A1 · Dedry et al. · 2015 [cited by applicant]
US 20150336096A1 · Smith et al. · 2015 [cited by applicant]
US 20160060680A1 · Buse et al. · 2016 [cited by applicant]
US 20160161516A1 · Fritchie et al. · 2016 [cited by applicant]
US 20160208216A1 · Vera et al. · 2016 [cited by applicant]
US 20160244714A1 · Spuhler et al. · 2016 [cited by applicant]
US 20160303563A1 · Granier · 2016 [cited by examiner]
US 20160320381A1 · Holmes · 2016 [cited by examiner]
US 20160320422A1 · Fritchie et al. · 2016 [cited by applicant]
US 20170058527A1 · Williams et al. · 2017 [cited by applicant]
US 20170307502A1 · Mason et al. · 2017 [cited by applicant]
US 20170313977A1 · Wilson · 2017 [cited by applicant]
US 20170321226A1 · Gill et al. · 2017 [cited by applicant]
US 20170348525A1 · Sano et al. · 2017 [cited by applicant]
US 20170362554A1 · Martin et al. · 2017 [cited by applicant]
US 20180031592A1 · Dority · 2018 [cited by applicant]
US 20180051243A1 · Hogan et al. · 2018 [cited by applicant]
US 20180078935A1 · Hung et al. · 2018 [cited by applicant]
US 20180185849A1 · Kaplan et al. · 2018 [cited by applicant]
US 20180196918A1 · Sadowski et al. · 2018 [cited by applicant]
US 20190212233A1 · Jovanovich et al. · 2019 [cited by applicant]
US 20190275519A1 · Castillo et al. · 2019 [cited by applicant]
US 20190292510A1 · Tandon et al. · 2019 [cited by applicant]
US 20190293673A1 · Wescott et al. · 2019 [cited by applicant]
US 20190316120A1 · Masquelier et al. · 2019 [cited by applicant]
US 20190330579A1 · Guenat et al. · 2019 [cited by applicant]
US 20200009557A1 · Frigard et al. · 2020 [cited by applicant]
US 20200025782A1 · Ahlfors · 2020 [cited by applicant]
US 20200048599A1 · Firouzi et al. · 2020 [cited by applicant]
US 20200095550A1 · Vera et al. · 2020 [cited by applicant]
US 20200159198A1 · Kapre et al. · 2020 [cited by applicant]
US 20200224147A1 · Rogers et al. · 2020 [cited by applicant]
US 20200283713A1 · Ball et al. · 2020 [cited by applicant]
US 20200292552A1 · Miltenyi et al. · 2020 [cited by applicant]
US 20200353004A1 · Nowak et al. · 2020 [cited by applicant]
US 20200368411A1 · Camisani et al. · 2020 [cited by applicant]
US 20200399578A1 · Corso et al. · 2020 [cited by applicant]
US 20200406221A1 · Dabrowski et al. · 2020 [cited by applicant]
US 20210001339A1 · Liu et al. · 2021 [cited by applicant]
US 20210032583A1 · Smith et al. · 2021 [cited by applicant]
US 20210035655A1 · Tanouchi et al. · 2021 [cited by applicant]
US 20210047668A1 · Dabrowski et al. · 2021 [cited by applicant]
US 20210079344A1 · Bosio et al. · 2021 [cited by applicant]
US 20210147807A1 · Lickert et al. · 2021 [cited by applicant]
US 20210253997A1 · Wilson · 2021 [cited by applicant]
US 20210269755A1 · Smith et al. · 2021 [cited by applicant]
US 20210283565A1 · Gerlinghaus et al. · 2021 [cited by applicant]
US 20210283606A1 · Thakkar et al. · 2021 [cited by applicant]
US 20210301239A1 · Natsume et al. · 2021 [cited by applicant]
US 20210324318A1 · Parietti et al. · 2021 [cited by applicant]
US 20220002652A1 · Patrick et al. · 2022 [cited by applicant]
US 20220003796A1 · Ahlfors · 2022 [cited by applicant]
US 20220047862A1 · Chang et al. · 2022 [cited by applicant]
US 20220121181A1 · Sobalvarro et al. · 2022 [cited by applicant]
US 20220143610A1 · Biz et al. · 2022 [cited by applicant]
US 20220150650A1 · Rucker · 2022 [cited by applicant]
US 20220259546A1 · Blanchard · 2022 [cited by applicant]
US 20220282199A1 · Vann · 2022 [cited by applicant]
US 20220325219A1 · Parietti et al. · 2022 [cited by applicant]
US 20220347683A1 · Thakkar et al. · 2022 [cited by applicant]
US 20230149922A1 · Azersky et al. · 2023 [cited by applicant]
US 20230321650A1 · Azersky et al. · 2023 [cited by applicant]
US 20230415154A1 · Pesch et al. · 2023 [cited by applicant]
US 20230415155A1 · Biz et al. · 2023 [cited by applicant]
US 20240165613A1 · Azersky et al. · 2024 [cited by applicant]
US 20240254426A1 · Elpel et al. · 2024 [cited by applicant]
US 20240255537A1 · Malleo et al. · 2024 [cited by applicant]
US 20240279585A1 · Griffin et al. · 2024 [cited by applicant]
US 20240279588A1 · Malleo et al. · 2024 [cited by applicant]
US 20240318116A1 · Chang et al. · 2024 [cited by applicant]
US 20240326043A1 · Gerlinghaus et al. · 2024 [cited by applicant]
US 20240369586A1 · Tian et al. · 2024 [cited by applicant]
US 20240377420A1 · Cesarek · 2024 [cited by applicant]
US 20240390897A1 · Azersky et al. · 2024 [cited by applicant]
US 20240390898A1 · Azersky et al. · 2024 [cited by applicant]
US 20240399365A1 · Biz et al. · 2024 [cited by applicant]
US 20240402206A1 · Boppart et al. · 2024 [cited by applicant]
CN 104203333A · 2014 [cited by applicant]
CN 108660060A · 2018 [cited by applicant]
EP 0246912A2 · 1987 [cited by applicant]
EP 0991389A1 · 2000 [cited by applicant]
EP 0824380B1 · 2002 [cited by applicant]
EP 3134512B1 · 2019 [cited by applicant]
EP 2809449B1 · 2019 [cited by applicant]
EP 3359294B1 · 2020 [cited by applicant]
EP 3928867A1 · 2021 [cited by applicant]
GB 2268187A · 1994 [cited by applicant]
JP 2007325586A · 2007 [cited by applicant]
KR 20130018286A · 2013 [cited by applicant]
WO WO9320440A1 · 1993 [cited by applicant]
WO WO2006102416A2 · 2006 [cited by applicant]
WO WO2006102416A3 · 2006 [cited by applicant]
WO WO2006112870A1 · 2006 [cited by applicant]
WO WO2006118282A1 · 2006 [cited by applicant]
WO WO2007139742A1 · 2007 [cited by applicant]
WO WO2009072003A2 · 2009 [cited by applicant]
WO WO2009072003A3 · 2009 [cited by applicant]
WO WO2017041051A1 · 2017 [cited by applicant]
WO WO2017123663A1 · 2017 [cited by applicant]
WO WO2018015561A1 · 2018 [cited by examiner]
WO WO2018102471A1 · 2018 [cited by applicant]
WO WO2020009700A1 · 2020 [cited by applicant]
WO WO2020014264A1 · 2020 [cited by applicant]
WO WO2021168368A1 · 2021 [cited by applicant]
WO WO2021183687A2 · 2021 [cited by applicant]
WO WO2021183687A3 · 2021 [cited by applicant]
WO WO2021212124A1 · 2021 [cited by applicant]
WO WO2024102996A1 · 2024 [cited by applicant]
WO WO2024112702A1 · 2024 [cited by applicant]
WO WO2024152008A1 · 2024 [cited by applicant]
WO WO2024197093A2 · 2024 [cited by applicant]
WO WO2024206703A1 · 2024 [cited by applicant]
WO WO2024233080A1 · 2024 [cited by applicant]
WO WO2024249904A1 · 2024 [cited by applicant]
ChargePoint (2021). Aseptic split butterfly valve 10-6 sterility assurance, located at https://www.thechargepoint.com/products/aseptic-split-butterfly-valve-10-6-sterility-assurance/, 2 total pages. [cited by applicant]
CPC (2014). “How single-use connections advance aseptic processing: Increased process flexibility and reliability, reduced costs,” White Paper 7004, 6 total pages. [cited by applicant]
CPC (2014). “6 traits of non-spill: How quick disconnect couplings evolved for low-pressure fluid handling,” White Paper 8004, 4 total pages. [cited by applicant]
CPC (2018). Comparison Guide: Tube Welders and Aseptic Connectors, Technical Guide 7009, 3 total pages. [cited by applicant]
EMD Millipore (2015). “Lynx® S2S Connector—Low temperature compatibility (-80 ° C.),” 4 total pages. [cited by applicant]
Garcia, P.A. et al. (2016). “Microfluidic screening of electric fields for electroporation,” Sci. Rep. 6:21238. [cited by applicant]
Genetic Engineering & Biotechnology News (2006). “Thermal welding for sterile connections,” located at https://www.genengnews.com/magazine/47/thermal-welding-for-sterile-connections/, 5 total pages. [cited by applicant]
MEDInstill (2021). Intact™ Connectors, located at https://www.medinstill.com/intact_connectors.php, 1 total page. [cited by applicant]
Millipore® (2020). “Technical Brief—Choosing the right sterile connector based on design and sterility test results.” 4 total pages. [cited by applicant]
Millipore Sigma (2020). “Lynx ® CDR Connectors,” Datasheet, 4 total pages. [cited by applicant]
Millipore Sigma (2021). Lynx ® CDR Connectors, located at https://www.emdmillipore.com/US/en/product/Lynx-CDR-Connectors,MM_NF-C188801, 2 total pages. [cited by applicant]
Saint Gobain (2017). “Pure-Fit® SC—Secure aseptic connections,” Brochure, 5 total pages. [cited by applicant]
Sartorius stedim biotech (2011). “Opta® SFT,” 4 total pages. [cited by applicant]
SeriesLock™ (2021). Features and Specifications, located at https://serieslock.com/, 5 total pages. [cited by applicant]
Steris (2018). “Sterility assurance levels (SALS): Irradiation,” 3 total pages. [cited by applicant]
Steris (2020). “Overview of sterilization technology comparison,” 1 total page. [cited by applicant]
Steris (2018). “A compilation of material compatibilities with vaporized hydrogen peroxide,” 2 total pages. [cited by applicant]
Strahlendorf, K.A. et al. (2009). “Bio Pharm International—A review of sterile connectors,” vol. 2009 Supplement, Issue 8, located at https://www.biopharminternational.com/view/review-sterile-connectors, 9 total pages. [cited by applicant]
Jain, S. et al. (2011). “The complete automation of cell culture: improvements for high-throughput and high-content screening,” J. Biomol. Screen 16:932-939. [cited by applicant]
Kato, R. et al. (2010). “A Compact, Automated Cell Culture System for Clinical Scale Cell Expansion from Primary Tissues,” Tissue Engineering: Part C 16:947-956. [cited by applicant]
Kempner, M.E. et al. (2002). “A review of cell culture automation,” JALA (J Assoc Lab Autom) 7:56-62. [cited by applicant]
Kino-Oka, M. et al. (2005). “Bioreactor Design for Successive Culture of Anchorage-Dependent Cells Operated in an Automated Manner,” Tissue Engineering 11:535-545. [cited by applicant]
Knoll, A. et al. (2004). “Flexible automation of cell culture and tissue engineering tasks,” Biotechnol. Prog. 20:1825-1835. [cited by applicant]
Lutkemeyer, D. et al. (2000). “First steps in robot automation of sampling and sample management during cultivation of mammalian cells in pilot scale,” Biotechnol. Prog. 16:822-828. [cited by applicant]
Non-Final Office Action mailed on Oct. 6, 2021, for U.S. Appl. No. 17/198,134, filed Mar. 10, 2021, 7 pages. [cited by applicant]
Non-Final Office Action mailed on Dec. 3, 2021, for U.S. Appl. No. 17/331,556, filed May 26, 2021, 9 pages. [cited by applicant]
Non-Final Office Action mailed on Feb. 3, 2022, for U.S. Appl. No. 17/198,134, filed Mar. 10, 2021, 5 pages. [cited by applicant]
Shi, Y. et al. (1992). “Performance of Mammalian Cell Culture Bioreactor with a New Impeller Design,” Blotechnology and Bioengineering 40:260-270. [cited by applicant]
Final Office Action mailed on Apr. 28, 2022, for U.S. Appl. No. 17/198,134, filed Mar. 10, 2021, 11 pages. [cited by applicant]
International Search Report mailed on Oct. 13, 2021, for PCT Application No. PCT/US2021/021773, filed on Mar. 10, 2021, 13 pages. [cited by applicant]
Notice of Allowance mailed on Mar. 1, 2022, for U.S. Appl. No. 17/331,556, filed May 26, 2021, 8 pages. [cited by applicant]
Qu, B. et al. (2012). “Droplet electroporation in microfluidics for efficient cell transformation with or without cell wall removal,” Lab Chip 12:4483-4488. [cited by applicant]
Schwartz, C. (2014). “Optimizing Cell Separation with Beckman Coulter's Centrifugal Elutriation System,” Beckmann Coulter Life Sciences, 6 total pages. [cited by applicant]
Written Opinion of the International Searching Authority mailed on Oct. 13, 2021, for PCT Application No. PCT/US2021/021773, filed on Mar. 10, 2021, 20 pages. [cited by applicant]
Non-Final Office Action mailed on Dec. 22, 2022, for U.S. Appl. No. 17/579,478, filed Jan. 19, 2022, 8 pages. [cited by applicant]
Final Office Action for U.S. Appl. No. 18/652,602 mailed Nov. 1, 2024, 29 pages. [cited by applicant]
Final Office Action for U.S. Appl. No. 18/731,095 mailed Nov. 26, 2024, 31 pages. [cited by applicant]
International Search Report and Written Opinion for PCT Application No. PCT/IB2024/058105 mailed Dec. 16, 2024, 12 pages. [cited by applicant]
International Search Report and Written Opinion for PCT Application No. PCT/US2024/032062 mailed Sep. 6, 2024, 15 pages. [cited by applicant]
International Search Report and Written Opinion for PCT Application No. PCT/US2024/042795 mailed Dec. 16, 2024, 11 pages. [cited by applicant]
Invitation to Pay Additional fees for International Application No. PCT/IB2024/058148, mailed Jan. 2, 2025, 13 pages. [cited by applicant]
Non-Final Office Action for U.S. Appl. No. 18/244,051 mailed Oct. 9, 2024, 10 pages. [cited by applicant]
Non-Final Office Action for U.S. Appl. No. 18/731,095 mailed Aug. 8, 2024, 24 pages. [cited by applicant]
Non-Final Office Action for U.S. Appl. No. 18/759,602 mailed Nov. 8, 2024, 10 pages. [cited by applicant]
Non-Final Office Action for U.S. Appl. No. 18/792,358 mailed on Nov. 6, 2024, 5 pages. [cited by applicant]
Non-Final Office Action for U.S. Appl. No. 18/799,963 mailed Sep. 30, 2024, 9 pages. [cited by applicant]
Non-Final Office Action for U.S. Appl. No. 18/810,386 mailed Nov. 18, 2024, 8 pages. [cited by applicant]
Notice of Allowance (Corrected) mailed on Sep. 5, 2024, for U.S. Appl. No. 18/611,632, filed Mar. 20, 2024, 6 pages. [cited by applicant]
Notice of Allowance for U.S. Appl. No. 18/611,632 mailed Aug. 26, 2024, 9 pages. [cited by applicant]
Notice of Allowance for U.S. Appl. No. 18/810,388 mailed on Oct. 9, 2024, 9 pages. [cited by applicant]
Notice of Allowance for U.S. Appl. No. 18/811,490 mailed on Dec. 12, 2024, 8 pages. [cited by applicant]
U.S. Appl. No. 18/807,699, filed Aug. 16, 2024, by Beban et al. [cited by applicant]
U.S. Appl. No. 29/898,923, filed Aug. 2, 2023, by Gerlinghaus et al. [cited by applicant]
U.S. Appl. No. 18/759,602, filed Jun. 28, 2024, by Thakkar et al. [cited by applicant]
Notice of Allowance mailed on Mar. 22, 2023, for U.S. Appl. No. 17/992,784, filed Nov. 22, 2022, 8 pages. [cited by applicant]
Final Office Action mailed on Mar. 31, 2023, for U.S. Appl. No. 17/579,478, filed Jan. 19, 2022, 8 pages. [cited by applicant]
Notice of Allowance mailed on Jun. 8, 2023, for U.S. Appl. No. 17/849,422, filed Jun. 24, 2022, 8 pages. [cited by applicant]
Non-Final Office Action mailed on Sep. 13, 2023, for U.S. Appl. No. 18/141,329, filed Apr. 28, 2023, 7 pages. [cited by applicant]
Notice of Allowance mailed on Oct. 4, 2023, for U.S. Appl. No. 18/141,329, filed Apr. 28, 2023, 8 pages. [cited by applicant]
Non-Final Office Action mailed on Jun. 26, 2023, for U.S. Appl. No. 17/198,134, filed Mar. 10, 2021, 15 pages. [cited by applicant]
Notice of Allowance mailed on Jul. 18, 2023, for U.S. Appl. No. 17/849,422, filed Jun. 24, 2022, 8 pages. [cited by applicant]
Notice of Allowance mailed on Jul. 25, 2023, for U.S. Appl. No. 17/579,478, filed Jan. 19, 2022, 8 pages. [cited by applicant]
International Search Report and Written Opinion for International Application No. PCT/US2023/080593 dated Mar. 21, 2024, 12 pages. [cited by applicant]
International Search Report and Written Opinion for PCT Application No. PCT/US2024/011486 dated May 24, 2024, 12 pages. [cited by applicant]
Invitation to Pay Additional Fee for International Application No. PCT/US2024/022079 dated Jul. 17, 2024, 19 pages. [cited by applicant]
Invitation to pay additional fees for International Application No. PCT/US2024/025064, mailed Jul. 16, 2024, 12 pages. [cited by applicant]
Non-Final Office Action for U.S. Appl. No. 18/652,602 mailed Jul. 17, 2024, 30 pages. [cited by applicant]
Non-Final Office Action mailed on May 14, 2024, for U.S. Appl. No. 18/611,632, filed Mar. 20, 2024, 13 pages. [cited by applicant]
Notice of Allowance mailed on Apr. 11, 2024, for U.S. Appl. No. 17/198,134, filed Mar. 10, 2021, 9 pages. [cited by applicant]
Pharma Japan, “Astellas Set to Cut Development Time with Cell Culture Robot, Eyes 4 Billion Yen Profit per Product” Aug. 9, 2023, 3 pages. [cited by applicant]
Cited By (5)
US 1,109,621 US 12,497,587 US 12,551,887 US 12,559,710 US 12,570,948